Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients
Top Cited Papers
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 64 (5), 507-516
- https://doi.org/10.1016/j.jclinepi.2010.11.018
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)Journal of Clinical Epidemiology, 2010
- The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008Journal of Clinical Epidemiology, 2010
- Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panelJournal of Clinical Epidemiology, 2010
- The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary diseaseHealth and Quality of Life Outcomes, 2008
- Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System InitiativeJournal of Clinical Oncology, 2007
- Minimally important change determined by a visual method integrating an anchor-based and a distribution-based approachQuality of Life Research, 2006
- Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue ScalesJournal of Pain and Symptom Management, 2002
- Group vs Individual Approaches to Understanding the Clinical Significance of Differences or Changes in Quality of LifeMayo Clinic Proceedings, 2002
- Fatigue in cancer patients compared with fatigue in the general United States populationCancer, 2002
- Measurement of health status: Ascertaining the minimal clinically important differenceControlled Clinical Trials, 1989